| ISIN | LU1660425346 |
|---|---|
| Valor Number | 37774288 |
| Bloomberg Global ID | |
| Fund Name | DNB Fund-Health Care A (ACC) EUR |
| Fund Provider |
DNB Asset Management AS
Stockholm, Sweden Phone: +46 8 473 41 00 Web: www.cim.se |
| Fund Provider | DNB Asset Management AS |
| Representative in Switzerland |
FundPartner Solutions (Suisse) SA Genève 75 |
| Distributor(s) |
Allfunds International Schweiz AG
DZ Private Bank (schweiz) AG
Fund Channel (Suisse) SA Nyon 2 Phone: +4122 0000 Swissquote Bank Gland Phone: +41 22 999 94 11 UBS AG Zürich Phone: +41 44 234 11 11 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | Emphasis is placed on investments in the equities of companies operating in or associated with the health care sectors. Geographically the Sub-Fund has full flexibility. The Sub-Fund may invest between 5% and 15% of its net assets in equities quoted on the Hong Kong Stock exchange or on the Shanghai Stock exchange. |
| Peculiarities |
| Current Price * | 18.22 EUR | 08.01.2026 |
|---|---|---|
| Previous Price * | 18.32 EUR | 07.01.2026 |
| 52 Week High * | 18.32 EUR | 07.01.2026 |
| 52 Week Low * | 14.40 EUR | 07.08.2025 |
| NAV * | 18.22 EUR | 08.01.2026 |
| Issue Price * | 18.22 EUR | 08.01.2026 |
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 112,415,927 | |
| Unit/Share Assets *** | 184,942 | |
| Trading Information SIX | ||
| YTD Performance | +3.08% |
31.12.2025 - 08.01.2026
31.12.2025 08.01.2026 |
|---|---|---|
| YTD Performance (in CHF) | +3.04% |
31.12.2025 - 08.01.2026
31.12.2025 08.01.2026 |
| 1 month | +5.08% |
08.12.2025 - 08.01.2026
08.12.2025 08.01.2026 |
| 3 months | +11.38% |
08.10.2025 - 08.01.2026
08.10.2025 08.01.2026 |
| 6 months | +21.59% |
08.07.2025 - 08.01.2026
08.07.2025 08.01.2026 |
| 1 year | +4.84% |
08.01.2025 - 08.01.2026
08.01.2025 08.01.2026 |
| 2 years | +9.88% |
08.01.2024 - 08.01.2026
08.01.2024 08.01.2026 |
| 3 years | +12.70% |
09.01.2023 - 08.01.2026
09.01.2023 08.01.2026 |
| 5 years | +45.92% |
08.01.2021 - 08.01.2026
08.01.2021 08.01.2026 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Eli Lilly and Co | 8.66% | |
|---|---|---|
| Johnson & Johnson | 6.33% | |
| AstraZeneca PLC | 6.32% | |
| Roche Holding AG | 6.20% | |
| Novo Nordisk AS Class B | 4.55% | |
| UnitedHealth Group Inc | 4.33% | |
| Sanofi SA | 3.84% | |
| DexCom Inc | 3.62% | |
| Thermo Fisher Scientific Inc | 3.38% | |
| Lonza Group Ltd | 3.33% | |
| Last data update | 30.11.2025 | |
| TER *** | 1.572% |
|---|---|
| TER date *** | 31.08.2025 |
| Performance Fee *** | 10.00% |
| PTR | |
| Max. Management Fee *** | 1.50% |
| Ongoing Charges *** | 1.57% |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |